4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-014321
President and CEO gave up 21,371 shares (to pay taxes)
- President and CEO acquired 61,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-17 | Exercise or conversion : show line 1 in the form | +61,800 | 146,331 | D | ||
| 2019-09-17 | Shares withheld for taxes : show line 2 in the form | −21,371 | $1.00 | $21,371 | 124,960 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-09-17 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −61,800 | 185,400 | D |
Loading xslF345X03/ownership.xml…